Envestnet Asset Management Inc Neurocrine Biosciences Inc Transaction History

Envestnet Asset Management Inc

  • $299 Billion
  • Q1 2025

A detailed history of Envestnet Asset Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 122,306 shares of NBIX stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,306
Previous 203,210 39.81%
Holding current value
$15.2 Million
Previous $27.7 Million 51.23%
% of portfolio
0.0%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025
SELL
$107.22 - $153.29 $8.67 Million - $12.4 Million
-80,904 Reduced 39.81%
122,306 $13.5 Million
Q4 2024

Feb 12, 2025
SELL
$111.62 - $139.44 $3.39 Million - $4.23 Million
-30,330 Reduced 12.99%
203,210 $27.7 Million
Q3 2024

Nov 06, 2024
BUY
$114.58 - $153.15 $3.52 Million - $4.71 Million
30,747 Added 15.16%
233,540 $26.9 Million
Q2 2024

Aug 08, 2024
BUY
$130.86 - $143.19 $444,400 - $486,273
3,396 Added 1.7%
202,793 $27.9 Million
Q1 2024

May 13, 2024
SELL
$130.4 - $143.74 $24,645 - $27,166
-189 Reduced 0.09%
199,397 $27.5 Million
Q4 2023

Feb 13, 2024
BUY
$106.07 - $132.76 $715,123 - $895,067
6,742 Added 3.5%
199,586 $26.3 Million
Q3 2023

Nov 13, 2023
BUY
$94.02 - $117.1 $10.4 Million - $13 Million
110,624 Added 134.55%
192,844 $21.7 Million
Q2 2023

Aug 04, 2023
SELL
$89.53 - $104.87 $29.1 Million - $34 Million
-324,562 Reduced 79.79%
82,220 $7.75 Million
Q1 2023

May 11, 2023
BUY
$94.11 - $123.02 $26.7 Million - $34.9 Million
283,315 Added 229.47%
406,782 $41.2 Million
Q4 2022

Feb 07, 2023
SELL
$106.72 - $127.06 $91,352 - $108,763
-856 Reduced 0.69%
123,467 $14.7 Million
Q3 2022

Nov 10, 2022
SELL
$92.03 - $107.81 $175,133 - $205,162
-1,903 Reduced 1.51%
124,323 $13.2 Million
Q2 2022

Aug 03, 2022
BUY
$75.79 - $100.07 $438,369 - $578,804
5,784 Added 4.8%
126,226 $12.3 Million
Q1 2022

May 04, 2022
BUY
$72.45 - $94.81 $2.57 Million - $3.36 Million
35,452 Added 41.71%
120,442 $11.3 Million
Q4 2021

Feb 04, 2022
SELL
$79.65 - $106.22 $1.05 Million - $1.4 Million
-13,160 Reduced 13.41%
84,990 $7.24 Million
Q3 2021

Oct 07, 2021
BUY
$86.18 - $99.03 $614,204 - $705,786
7,127 Added 7.83%
98,150 $9.41 Million
Q2 2021

Aug 04, 2021
BUY
$89.43 - $102.27 $221,249 - $253,015
2,474 Added 2.79%
91,023 $8.86 Million
Q1 2021

May 04, 2021
BUY
$87.57 - $119.4 $754,940 - $1.03 Million
8,621 Added 10.79%
88,549 $8.61 Million
Q4 2020

Feb 02, 2021
BUY
$86.91 - $108.33 $32,504 - $40,515
374 Added 0.47%
79,928 $7.66 Million
Q3 2020

Oct 09, 2020
BUY
$96.16 - $135.15 $3.11 Million - $4.38 Million
32,384 Added 68.65%
79,554 $7.65 Million
Q2 2020

Jul 08, 2020
BUY
$85.09 - $130.36 $317,215 - $485,982
3,728 Added 8.58%
47,170 $5.76 Million
Q1 2020

Apr 23, 2020
BUY
$75.11 - $113.76 $547,251 - $828,855
7,286 Added 20.15%
43,442 $3.76 Million
Q4 2019

Feb 11, 2020
BUY
$86.8 - $118.57 $87,668 - $119,755
1,010 Added 2.87%
36,156 $3.89 Million
Q3 2019

Oct 17, 2019
BUY
$83.82 - $101.5 $337,543 - $408,740
4,027 Added 12.94%
35,146 $3.17 Million
Q2 2019

Aug 02, 2019
BUY
$72.24 - $91.27 $204,366 - $258,202
2,829 Added 10.0%
31,119 $2.63 Million
Q1 2019

May 10, 2019
BUY
$69.31 - $91.53 $574,371 - $758,509
8,287 Added 41.43%
28,290 $2.49 Million
Q4 2018

Feb 13, 2019
BUY
$68.32 - $124.36 $1.37 Million - $2.49 Million
20,003 New
20,003 $1.43 Million
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $49,143 - $62,547
-497 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$75.3 - $105.99 $6,927 - $9,751
92 Added 22.72%
497 $49,000
Q1 2018

May 09, 2018
BUY
$75.88 - $92.43 $4,021 - $4,898
53 Added 15.06%
405 $34,000
Q4 2017

Feb 20, 2018
SELL
$58.53 - $77.59 $1,463 - $1,939
-25 Reduced 6.63%
352 $27,000
Q3 2017

Nov 13, 2017
SELL
$47.97 - $61.28 $18,516 - $23,654
-386 Reduced 50.59%
377 $23,000
Q2 2017

Aug 14, 2017
BUY
N/A
763
763 $35,000

Others Institutions Holding NBIX

# of Institutions
649
Shares Held
97.1M
Call Options Held
749K
Put Options Held
553K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email